Esophageal Cancer
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2007; 13(16): 2283-2288
Published online Apr 28, 2007. doi: 10.3748/wjg.v13.i16.2283
Figure 1
Figure 1 Schedule of preoperative CRT.
Figure 2
Figure 2 COX-2 or VEGF expression in ESCC tissue. A: Strong COX-2 expression (A-1; × 40, A-2; × 200); B: Strong VEGF expression (B-1; × 40, B-2; × 200). Bar indicates 100 μm.
Figure 3
Figure 3 Disease-free survival differences between patients with no residual tumor or null COX-2 expression, and those with positive COX-2 expression.